United States · Bill · S
S. 2817 (116th)
End Price Gouging for Insulin Act
Introduced
7 November 2019
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6479-6480)
Sponsors
—
Subjects
Discovery layer
Source updated
5 December 2025
Summary
End Price Gouging for Insulin Act This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 7 November 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 7 November 2019
Introduced in Senate
summary · EN · 7 November 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/2817
- Open data entity: https://api.congress.gov/v3/bill/116/s/2817